Mizuho Praises Bloom Energy at $207-Why the 'Buy' Case Is Hot, and Why It Could Still Burn You

Bloom at $207: Mizuho's upgrade helped, but the easy upside may already be gone

Bloom now has the AI power narrative, but it also has more exposure after its run. The stock last traded at $207.1940 after a 26.5% midday jump following Mizuho's upgrade to Outperform and a $242 price target. After closing at $163.75 the previous session, that leaves only about $35, or roughly 17%, of upside to Mizuho's target. This is no longer a quiet idea waiting to be discovered.

The real question is whether Bloom is still underpriced or already too loved.

My view: Bloom is still interesting, but this is no longer a bargain hunt. At this level, you are paying for follow-through. If demand stays strong and execution keeps improving, the stock can still work toward $242. If not, the move may have been too fast.

Why Mizuho is bullish: Bloom is selling power infrastructure, not just a concept

Bloom's product has a clear use case

The bull case works only if Bloom can deliver electricity where customers actually need it, not just in a long-dated model. That is the practical appeal investors keep coming back to: Bloom's solid oxide fuel cells can sit near the load and provide distributed power from natural gas, biogas, or hydrogen without combustion distributed power using fuels such as natural gas, biogas, or hydrogen. For data centers, that matters. Mizuho's thesis is tied directly to data center power demand and rising demand for energy sources from hyperscalers to power their data centers.

Recent results help, but execution is still the test

Bloom's recent quarter helps explain the excitement. The company reported $1.07 billion in Q2 revenue and $0.78 in Q2 EPS, both ahead of Wall Street expectations, and Mizuho highlighted strong quarterly results as part of its upgrade. That does not prove every growth assumption is correct, but it does show the business is getting attention for current performance, not only future promises.

The bigger question is whether Bloom can scale fast enough to convert demand into sustained execution. Mizuho argues it can. The firm says Bloom is targeting 2 GW of fuel cell manufacturing capacity by the end of 2026, up from 1 GW today, and that milestone was accelerated by three years from the prior plan. Mizuho also pointed to a "time-to-power advantage" and $27B of financing capacity. In practical terms, that could help Bloom move faster than peers and make projects easier to finance.

What would validate the bull case

The stronger signals from here are straightforward:

• Manufacturing capacity actually ramps toward the 2 GW goal.
• Sales growth keeps improving as Mizuho expects, with megawatts sold projected to expand at a faster pace.
• Customers keep showing up, especially in data center power, where demand is rising.

If those pieces line up, Bloom has a credible path to supporting its AI-power narrative. If not, the stock could struggle under the weight of higher expectations.

Is Bloom a buy here, or just another AI-infrastructure trade?

At this level, Bloom looks more like an AI power trade built on real hardware than a sleepy clean-energy story. That matters because crowded trades can keep running, but they can also unwind quickly when expectations get too high.

The market is clearly divided, and that debate is useful. Recent Wall Street views range from BMO's $227 target and Citigroup's hold to Susquehanna's $298 target, while one MarketBeat tabulation shows a $246.18 average target and another source cites a $280.29 average target. That spread tells you investors still disagree about how much of the story is already in the price.

My read: be selective from here

This is not a clear "buy anywhere" stock after a move of this size. It is more compelling for investors who want proof that capacity, demand, and financing are all advancing together. Bloom is not selling an abstract concept: it provides distributed power using fuels such as natural gas, biogas, or hydrogen. But at roughly $207, the stock already reflects a lot of that narrative.

I would lean toward waiting for clearer evidence rather than chasing the momentum blindly. A fresh rerating, continued execution, or visible progress on the manufacturing buildout would make the case stronger. If the company slips on those fronts, the stock could prove much more sensitive to disappointment than the headlines suggest.